NCT06066918 is a NA clinical trial of Pregabalin 75mg in Spinal Cord Injuries, sponsored by Loewenstein Hospital.

Who is sponsoring NCT06066918?

NCT06066918 is sponsored by Loewenstein Hospital.

What drugs are being tested in NCT06066918?

Interventions in NCT06066918: Pregabalin 75mg.

What condition does NCT06066918 study?

NCT06066918 studies Spinal Cord Injuries, Spinal Cord Diseases.

Is NCT06066918 still recruiting?

NCT06066918 is currently recruiting now. Last updated 24 June 2025.

Last reviewed 2025-06-24 · How we verify

NCT06066918

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prophylactic Pregabalin Treatment Following Spinal Cord Injury

Recruiting now NA Last updated 24 June 2025

What this trial tests

NA trial testing Pregabalin 75mg in Spinal Cord Injuries in 50 participants. Currently enrolling.

Timeline

13 July 2021

Primary endpoint
5 February 2026

5 February 2026

Quick facts

Lead sponsor	Loewenstein Hospital
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	50
Start date	13 July 2021
Primary completion	5 February 2026
Estimated completion	5 February 2026
Sites	1 location across Israel

Drugs / interventions tested

Pregabalin 75mg — full drug profile →

Conditions studied

Spinal Cord Injuries — all drugs for Spinal Cord Injuries →
Spinal Cord Diseases — all drugs for Spinal Cord Diseases →

Sponsor

Loewenstein Hospital

Who can join

18 and older, any sex, with Spinal Cord Injuries or Spinal Cord Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients arriving to rehabilitation up to 3 months following SCI will be given (study group) or not (control group) Lyrica (75X2). They will be followed for central pain development.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Pregabalin 75mg

Trials testing the same drug.

NCT06271486 — Pregabalin in Treatment of Postdural Puncture Headache · Phase 3 · completed
NCT06187922 — Effect of Perioperative Oral Pregabalin in Total Knee Replacement · Phase 4 · unknown
NCT04666714 — Efficacy and Safety of Praga Formulation in the Treatment of Neuropathic Pain · Phase 3 · recruiting
NCT05460871 — Pregabalin for Central Sensitization in TKA · Phase 4 · terminated
NCT06025474 — Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome · Phase 3 · unknown

Other recruiting trials for Spinal Cord Injuries

Currently open trials in the same condition.

NCT07109804 — Cuneiform Nucleus (CnF) Deep Brain Stimulation for Gait Facilitation Following Spinal Cord Injury · NA · recruiting
NCT07472985 — Protocol for Rapid Onset of Mobilization in Patients With Traumatic Spinal Cord Injury II (PROMPT-SCI II) Trial · NA · recruiting
NCT07210411 — Acute and Chronic Repercussion of Spinal Cord Stimulation After Spinal Cord Injury · NA · recruiting
NCT07488793 — Remote Ischemic Conditioning for PwSCI · NA · recruiting
NCT07536386 — Self-balancing Personal Exoskeleton for SCI (WIP) · NA · recruiting

Other Loewenstein Hospital trials

Trials by the same sponsor.

NCT05482022 — Speaking Valve Influence on Breathing, Swallowing and Vocal Functions in Patients With Tracheostomy. · NA · recruiting
NCT04229329 — Effects of Intensive Training on Reocvery of Fingers Dexterity Following Stroke · Phase 1, PHASE2 · unknown
NCT03855930 — Phantom Limb Pain Triggered by Micturition · unknown
NCT03621423 — The Use of Ultrasound for Botulinum Toxin Subscapularis Muscle Injection Guidance in Spastic Hemiplegic Shoulder Pain · NA · unknown
NCT03593291 — LMWH-VTE Prophylaxis for Survivors of Acute Ischemic Stroke- Assessment of Standard Dosing Regimen · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06066918 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Loewenstein Hospital
Last refreshed: 24 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06066918.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing